echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The first anniversary of the production of the belt purchase, Hebei patients save 3.559 billion yuan in drug costs

    The first anniversary of the production of the belt purchase, Hebei patients save 3.559 billion yuan in drug costs

    • Last Update: 2020-07-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network Industry Dynamics From July 1, 2019, Hebei Province followed up with the implementation of the state-organized drug centralized procurement and use of the pilot work officially launchedthrough the volume of procurement, the first batch of 25 selected drugs low procurement prices decreased by an average of 52%, a high decline of 96%, drug prices significantly decreasednow a year has passed since Hebei Province began to purchase the amount of production, what is the current result? According to the Hebei Health Insurance Bureau, from July 1st, 19th to June 30th this year, the first procurement cycle in Hebei Province endedthe province's total procurement of 63.7264 million boxes of selected drugs, more than the agreed procurement volume of 241.22%, reducing the burden of medical expenses of the masses 3.559 billion yuancan be seen, the promotion of the volume of procurement, indeed greatly reduced the burden of the patient's drug costsmid-January 2020, the State Administration of Medical Security carried out the second batch of centralized procurement of state-organized drugs, with a total of 32 varieties selectedin order to allow patients to use the high-quality and affordable drugs as soon as possible, Hebei Province from April 1 to implement the results of the electionthe second batch of sourcinals covers a number of therapeutic areas, including oral sugar-lowering drugs such as apranos, gremetrice, omethatinestin, candacetamestin, and pyrapa; avariety tablets for the treatment of the rare lung artery hypertension; anti-cancer drug yewol, digio, abitron; and azithromycin, metrice, coryinne, cyclosporine, and other antibioticsaccording to statistics, Hebei Province to implement the second batch of state-organized drug centralized procurement of the annual procurement volume of about 438 million units / tablet, 32 selected varieties of the average price reduction range of 72.81 percent, is expected to save 390 million yuan in annual medical costsin order to ensure the smooth implementation of the second batch of volume procurement, Hebei Provincial Medical Security Bureau has formulated three safeguardsone is the contractual agreementmedical institutions, selected production enterprises, distribution enterprises three parties to sign a volume purchase and sale contract, the winning enterprises must be in accordance with the contract to ensure the supply of drugs; After the signing of thecontract, the medical insurance fund shall advance to the medical institution according to 50% of the purchase amount agreed upon in the contract, and as the working capital of the medical institution to pay the purchase of medicines to the enterprise, the special funds shall be used exclusively, and the medical institution shall not exceed 30 days from the acceptance of the receipt to the acceptance of the receipt to the payment to the enterpriseencourage the direct settlement of the medical insurance operators and enterprises in the conditional co-ordination areathrough timely repayment, reduce the cost of enterprises, to ensure production;, together with the relevant departments, has established a system of emergency reserves, inventory and production stoppage reporting for production enterprises , in the implementation of the drug can not guarantee the quality and quantity of drugs, such as compensation, discipline, withdrawal, alternative and emergency protection and other measures to ensure the quality and supply of drugs, to ensure the safety of patients in addition, , in order to strengthen the centralized procurement work of scientific, institutionalized, fine management, regulate the centralized procurement behavior, a few days ago, Hebei Provincial Medical Security Bureau also issued "on further strengthening the centralized procurement work management and related issues notice", clear the provincial medical security bureau on the province's centralized procurement work to carry out overall planning, to avoid centralized procurement work "local fight" "variety fight" problem the province's medical security departments at all levels to participate in the organization of centralized procurement in foreign provinces and cities, cross-district city procurement alliances need to be reported in advance to the provincial medical security bureau for examination in the industry's view, the normality of volume procurement is reshaping the entire pharmaceutical industry pattern policy is clear, that is, health insurance fees, reduce the burden of drug use patients also helps to fund its price-cutting balance to include more innovative drugs, high-difficult generics and clinically urgently needed drugs in health care rules, the previous high prices are unsustainable , the market share in the hospital is expected to be very small, as the winning drug will gain more market share than the failed drug on the whole, the days of high gross margins for genericdrugs are gone
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.